Mauricio Plata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mauricio Plata has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
- Juan Ignacio Caicedo
Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
15 shared publications Carlos Gustavo Trujillo
Department of Urology Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine Bogotá Distrito Capital Colombia
10 shared publications- Alejandra Bravo-Balado
Stone Unit, Department of Urology Fundació Puigvert, Autonoma University of Barcelona Barcelona Spain
8 shared publications - Carlos Gustavo Trujillo
Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
8 shared publications Daniela Robledo
Department of Urology Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine Bogotá Distrito Capital Colombia
7 shared publicationsJessica Santander
Department of Urology Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine Bogotá Colombia
6 shared publications
Latest Publications
- Open Access
- 1 April 2025
- Published by Elsevier in Continence
- Vol. 14
ICS teaching module on urodynamics for lower urinary tract symptoms in men
- 1 April 2025
- Published by Elsevier in Continence
- Vol. 14
Open AccessICS teaching module on urodynamics for lower urinary tract symptoms in men
- 24 March 2023
- Published by Springer Nature in World Journal of Urology
- Vol. 41 (5) , 1381-1388
Anxiety and depression in association with lower urinary tract symptoms: results from the COBaLT study
Purpose Depression and anxiety have been associated with lower urinary tract symptoms (LUTS) in several studies. In our population, the prevalence of LUTS is high, consequently, it is essential and an objective of this study, to determine the association between anxiety, depression, and LUTS in a large Hispanic population. Methods A sub-analysis of a cross‐sectional population‐based study to estimate LUTS prevalence in the Colombian population was performed (COBaLT study) (Plata et al. in Neurourol Urodyn 38:200–207, 2018). The Hospital Anxiety and Depression Scale (HADS) was used to evaluate mental health. Logistic regression was carried out to estimate the association of depression and anxiety with different LUTS. Variables that proved statistically significant (p < 0.05) were included in a multivariate model. Results A total of 1060 individuals were assessed. The prevalence of anxiety in women and men was 17.1% and 6.7%, respectively. Depression in women and men was 20.1% and 9.4%, respectively. An association was found between anxiety and overactive bladder (OAB) without urinary incontinence (OR = 3.7) and moderate or severe LUTS in men (OR = 3.8). In women, anxiety was associated with nocturia (OR = 4.2) and stress urinary incontinence (OR = 2.4). For depression, an association was found between sexual dysfunction (OR = 4.3) and moderate or severe LUTS (OR = 4.0) in men; while in women it was associated with stress urinary incontinence (OR = 2.3), the sensation of incomplete emptying (OR = 1.7) and decreased frequency of sexual activity (OR = 1.8). Conclusions The associations found are consistent with other reports. It is essential to inquire about possible symptoms related to the mental sphere in the urology consultation to make appropriate referrals and subsequent management.
- 24 March 2023
- Published by Springer Nature in World Journal of Urology
- Vol. 41 (5) , 1381-1388
Anxiety and depression in association with lower urinary tract symptoms: results from the COBaLT study
Purpose Depression and anxiety have been associated with lower urinary tract symptoms (LUTS) in several studies. In our population, the prevalence of LUTS is high, consequently, it is essential and an objective of this study, to determine the association between anxiety, depression, and LUTS in a large Hispanic population. Methods A sub-analysis of a cross‐sectional population‐based study to estimate LUTS prevalence in the Colombian population was performed (COBaLT study) (Plata et al. in Neurourol Urodyn 38:200–207, 2018). The Hospital Anxiety and Depression Scale (HADS) was used to evaluate mental health. Logistic regression was carried out to estimate the association of depression and anxiety with different LUTS. Variables that proved statistically significant (p < 0.05) were included in a multivariate model. Results A total of 1060 individuals were assessed. The prevalence of anxiety in women and men was 17.1% and 6.7%, respectively. Depression in women and men was 20.1% and 9.4%, respectively. An association was found between anxiety and overactive bladder (OAB) without urinary incontinence (OR = 3.7) and moderate or severe LUTS in men (OR = 3.8). In women, anxiety was associated with nocturia (OR = 4.2) and stress urinary incontinence (OR = 2.4). For depression, an association was found between sexual dysfunction (OR = 4.3) and moderate or severe LUTS (OR = 4.0) in men; while in women it was associated with stress urinary incontinence (OR = 2.3), the sensation of incomplete emptying (OR = 1.7) and decreased frequency of sexual activity (OR = 1.8). Conclusions The associations found are consistent with other reports. It is essential to inquire about possible symptoms related to the mental sphere in the urology consultation to make appropriate referrals and subsequent management.
- 21 July 2022
- Published by Wiley in Neurourology and Urodynamics
- Vol. 41 (7) , 1573-1581
Performance of the artificial urinary sphincter implantation in men with urinary incontinence: Results from a contemporary long‐term real‐world nationwide analysis
Purpose: The artificial urinary sphincter (AUS) is one of the most effective surgical treatments for male urinary incontinence regardless of its severity. Current knowledge comes from high‐volume centers, but little is known about the performance of this surgery from community practices. This study aims to report contemporary AUS performance in a nationwide observational study in Colombia.Methods: Male patients who underwent AUS surgery with AMS 800™ between 2000 and 2020 in more than 17 centers and four cities were identified. Pre, intra, and postoperative characteristics were evaluated, mainly addressing patient reported outcomes measurements in the postoperative period. Retrospective and prospective data collection and descriptive analysis were completed. Kaplan‐Meier analysis was used to determine AUS survival rate.Results: Out of an initial 667 cases, a total of 215 patients met inclusion and exclusion criteria and were included. Mean age was 67 ± 9.4 years, and mean follow‐up was 6.0 ± 4.4 years with maximum range of 14 years. The etiology of urinary incontinence was prostate cancer surgery in 141 (81%) of the cases. The rest of the cases were related to benign prostatic disease or spinal cord injury. It is noteworthy that out of 115 patients, only 59 (51.3%) reported previous formal pelvic floor rehabilitation. Subjective severity of urinary incontinence determined by a visual analog scale showed a decrease in 4.5 points after sphincter implantation. Sphincter removal was required in 50 (23.2%) cases. The main reasons for implant removal were urethral erosion and infection. The sphincter survival rate at 2, 5, 8, 10, and 14 years was 76%, 70%, 60%, 57%, and 17%, respectively. Of the subjects at the last follow‐up with the device still in place, 80.7% defined their urinary condition as “does not cause or causes minor discomfort,” and 99% would recommend the device to a friend or relative in the same condition.Conclusions: This series from a community‐based practice shows the lack of adherence to clinical practice guidelines and the lack of standardized data collection. In contrast, this study provides real‐world data on explantation and revision rates, allows physicians to inform patients and to have clear metrics for a shared decision‐making process before the procedure.
- 21 July 2022
- Published by Wiley in Neurourology and Urodynamics
- Vol. 41 (7) , 1573-1581
Performance of the artificial urinary sphincter implantation in men with urinary incontinence: Results from a contemporary long‐term real‐world nationwide analysis
Purpose: The artificial urinary sphincter (AUS) is one of the most effective surgical treatments for male urinary incontinence regardless of its severity. Current knowledge comes from high‐volume centers, but little is known about the performance of this surgery from community practices. This study aims to report contemporary AUS performance in a nationwide observational study in Colombia.Methods: Male patients who underwent AUS surgery with AMS 800™ between 2000 and 2020 in more than 17 centers and four cities were identified. Pre, intra, and postoperative characteristics were evaluated, mainly addressing patient reported outcomes measurements in the postoperative period. Retrospective and prospective data collection and descriptive analysis were completed. Kaplan‐Meier analysis was used to determine AUS survival rate.Results: Out of an initial 667 cases, a total of 215 patients met inclusion and exclusion criteria and were included. Mean age was 67 ± 9.4 years, and mean follow‐up was 6.0 ± 4.4 years with maximum range of 14 years. The etiology of urinary incontinence was prostate cancer surgery in 141 (81%) of the cases. The rest of the cases were related to benign prostatic disease or spinal cord injury. It is noteworthy that out of 115 patients, only 59 (51.3%) reported previous formal pelvic floor rehabilitation. Subjective severity of urinary incontinence determined by a visual analog scale showed a decrease in 4.5 points after sphincter implantation. Sphincter removal was required in 50 (23.2%) cases. The main reasons for implant removal were urethral erosion and infection. The sphincter survival rate at 2, 5, 8, 10, and 14 years was 76%, 70%, 60%, 57%, and 17%, respectively. Of the subjects at the last follow‐up with the device still in place, 80.7% defined their urinary condition as “does not cause or causes minor discomfort,” and 99% would recommend the device to a friend or relative in the same condition.Conclusions: This series from a community‐based practice shows the lack of adherence to clinical practice guidelines and the lack of standardized data collection. In contrast, this study provides real‐world data on explantation and revision rates, allows physicians to inform patients and to have clear metrics for a shared decision‐making process before the procedure.
- 1 November 2021
- Published by SAGE Publications in Journal of Endourology
- Vol. 35 (11) , 1665-1670
Changing Paradigms: Green Laser Vaporization for Prostates over 80 mL: A Comparative Study
Introduction and Objectives: Benign prostatic enlargement (BPE) and big prostates are common. Photovaporization of the prostate (PVP) with Greenlight™ laser 180 W XPS is considered a reliable therapy for prostates p < 0.001). Efficacy was similar between groups, with a reduction of ≥4 points in IPSS score in 83.1% and 89.5% in Groups 1 and 2 ( p = 0.053), PSA drop was 1 ± 2.6 and 1.7 ± 4.7 ( p = 0.32). Group 2 had a higher conversion rate (0.3% vs 4.9%, p < 0.001) and higher blood transfusion rate (0% vs 2.4%, p < 0.001). There were no differences in hospital stay, catheterization time, urethral stricture, or re-treatment rates. Conclusions: GreenLight PVP is a safe and effective procedure in prostates ≥80 mL. It shows the same advantages demonstrated for those under that volume, particularly short hospital stay and catheterization time. Surgeon's experience is important to avoid complications, such as conversion and transfusion. PVP should be considered a first-line alternative for the treatment of bigger prostates.
- 1 November 2021
- Published by SAGE Publications in Journal of Endourology
- Vol. 35 (11) , 1665-1670
Changing Paradigms: Green Laser Vaporization for Prostates over 80 mL: A Comparative Study
Introduction and Objectives: Benign prostatic enlargement (BPE) and big prostates are common. Photovaporization of the prostate (PVP) with Greenlight™ laser 180 W XPS is considered a reliable therapy for prostates p < 0.001). Efficacy was similar between groups, with a reduction of ≥4 points in IPSS score in 83.1% and 89.5% in Groups 1 and 2 ( p = 0.053), PSA drop was 1 ± 2.6 and 1.7 ± 4.7 ( p = 0.32). Group 2 had a higher conversion rate (0.3% vs 4.9%, p < 0.001) and higher blood transfusion rate (0% vs 2.4%, p < 0.001). There were no differences in hospital stay, catheterization time, urethral stricture, or re-treatment rates. Conclusions: GreenLight PVP is a safe and effective procedure in prostates ≥80 mL. It shows the same advantages demonstrated for those under that volume, particularly short hospital stay and catheterization time. Surgeon's experience is important to avoid complications, such as conversion and transfusion. PVP should be considered a first-line alternative for the treatment of bigger prostates.
- 1 March 2021
- Published by Wiley in Neurourology and Urodynamics
- Vol. 40 (3) , 868-875
Impact of detrusor underactivity on the postoperative outcomes after benign prostatic enlargement surgery
Introduction and Objective: Previous studies suggest that men with detrusor underactivity (DUA) have less symptomatic improvement after prostate surgery than those with normal contractility, but the available data is controversial. We aim to determine the differences in functional outcomes of patients with or without DUA who underwent photovaporization of the prostate (PVP) with GreenLight™180 W XPS.Methods: A cohort of patients with lower urinary tract symptoms (LUTS) who underwent PVP between 2012 and 2019 was evaluated. Patients were stratified according to bladder contractility index (BCI). DUA was defined as BCI < 100. Those with normal contractility (BCI = 100–150) were included in Group 1, and those with DUA (BCI < 100) in Group 2. Primary outcomes were symptomatic improvement defined as a reduction ≥ 4 points in the international prostate symptom score (IPSS) and a reduction of at least 1 point in the quality of life (IPSS‐QoL). Complications according to the Clavien–Dindo classification were also recorded.Results: A total of 271 patients who underwent PVP with GreenLight™ and met the inclusion criteria were assessed. Group 1 included 158 patients, while Group 2 included 113 patients. Mean follow‐up was 24 months. Patients with normal contractility had a median reduction of 11 points (18.9 ± 8.0 to 7.1 ± 7.0) while patients with DUA had a median reduction of 10 points (19.3 ± 6.9 to 8.6 ± 8.4) in IPSS score; these differences were not statistically significant (p = .20). Patients in Group 1 had a 1.92 higher chance of QoL improvement (OR, 1.92; 90% CI, 1.10–3.37), compared to those in Group 2. Failure to void after PVP was most frequently reported in DUA patients (OR, 2.36; 90% CI, 1.26–4.43). Sociodemographic characteristics, intraoperative complications, conversion rates, hospital stay, and urinary catheterization time were similar between groups.Conclusions: Patients with LUTS, regardless of their BCI, improved their symptoms after PVP according to the IPSS. However, patients with DUA were more likely not to improve their QoL after the procedure and had a higher chance of failure to void in the immediate postoperative period. An appropriate counseling process with the patient discussing possible outcomes based on these findings should be encouraged.
- 1 March 2021
- Published by Wiley in Neurourology and Urodynamics
- Vol. 40 (3) , 868-875
Impact of detrusor underactivity on the postoperative outcomes after benign prostatic enlargement surgery
Introduction and Objective: Previous studies suggest that men with detrusor underactivity (DUA) have less symptomatic improvement after prostate surgery than those with normal contractility, but the available data is controversial. We aim to determine the differences in functional outcomes of patients with or without DUA who underwent photovaporization of the prostate (PVP) with GreenLight™180 W XPS.Methods: A cohort of patients with lower urinary tract symptoms (LUTS) who underwent PVP between 2012 and 2019 was evaluated. Patients were stratified according to bladder contractility index (BCI). DUA was defined as BCI < 100. Those with normal contractility (BCI = 100–150) were included in Group 1, and those with DUA (BCI < 100) in Group 2. Primary outcomes were symptomatic improvement defined as a reduction ≥ 4 points in the international prostate symptom score (IPSS) and a reduction of at least 1 point in the quality of life (IPSS‐QoL). Complications according to the Clavien–Dindo classification were also recorded.Results: A total of 271 patients who underwent PVP with GreenLight™ and met the inclusion criteria were assessed. Group 1 included 158 patients, while Group 2 included 113 patients. Mean follow‐up was 24 months. Patients with normal contractility had a median reduction of 11 points (18.9 ± 8.0 to 7.1 ± 7.0) while patients with DUA had a median reduction of 10 points (19.3 ± 6.9 to 8.6 ± 8.4) in IPSS score; these differences were not statistically significant (p = .20). Patients in Group 1 had a 1.92 higher chance of QoL improvement (OR, 1.92; 90% CI, 1.10–3.37), compared to those in Group 2. Failure to void after PVP was most frequently reported in DUA patients (OR, 2.36; 90% CI, 1.26–4.43). Sociodemographic characteristics, intraoperative complications, conversion rates, hospital stay, and urinary catheterization time were similar between groups.Conclusions: Patients with LUTS, regardless of their BCI, improved their symptoms after PVP according to the IPSS. However, patients with DUA were more likely not to improve their QoL after the procedure and had a higher chance of failure to void in the immediate postoperative period. An appropriate counseling process with the patient discussing possible outcomes based on these findings should be encouraged.
- 7 February 2021
- Published by Wiley in Neurourology and Urodynamics
- Vol. 40 (3) , 819-828
Potential associations of adult nocturia. Results from a national prevalence study
Aim: To determine the prevalence of nocturia and associated risk factors in the Colombian population aged ≥18 years old.Methods: This is a cross‐sectional population‐based study conducted in 1060 participants in Colombia. Nocturia was assessed with the Spanish version of the ICIQ‐OAB, using the ICS terminology. Descriptive statistics were used to evaluate nocturia prevalence. Logistic regression analysis was carried out to determine the association of nocturia with predefined variables.Results: The prevalence of nocturia was 55.9% and it was more common in women than men (53.96% vs. 46.04%; p = .004). At least three episodes of nocturia were observed in 20.37% of the participants who had a severe alteration in their quality of life (p < .01). The bivariate model showed an association between nocturia and obesity (odds ratio [OR], 1.69; 90% confidence interval [CI]: 1.22–2.34), diabetes mellitus (OR, 2.99; 90% CI: 1.86–4.83), high blood pressure (OR, 2.04; 90% CI: 1.52–2.72), cardiovascular disease (OR, 1.75; 90% CI: 1.08 – 2.83), depression (OR, 1.89; 90% CI: 1.23–2.89), obstructive sleep apnea (OR, 1.70; 90% CI: 1.17 ‐ 2.46), and childhood enuresis (OR, 1.45; 90% CI: 1.04–2.02). The multivariate model showed an association with obesity (OR, 2.0; 95% CI: 1.14 ‐ 3.51) in women, as well as age ≥ 65 years (OR, 3.18; 95% CI: 1.26 – 8.02) and erectile dysfunction (OR, 3.44; 95% CI: 1.21 – 9.72) in men. Childhood enuresis was significantly associated with nocturia in both genders (OR, 1.61; 95% CI: 1.09 ‐ 2.40 in women and OR, 1.66; 95% CI: 1.09–2.52 in men).Conclusion: There is a significant prevalence of nocturia in our population and a clear association with impaired quality of life. We consider important to inquire about history of childhood enuresis to define the risk of presenting nocturia in adulthood. Nocturia was associated with multiple comorbidities. Obesity and erectile dysfunction play an important role as modifiable risk factor.
- 7 February 2021
- Published by Wiley in Neurourology and Urodynamics
- Vol. 40 (3) , 819-828
Potential associations of adult nocturia. Results from a national prevalence study
Aim: To determine the prevalence of nocturia and associated risk factors in the Colombian population aged ≥18 years old.Methods: This is a cross‐sectional population‐based study conducted in 1060 participants in Colombia. Nocturia was assessed with the Spanish version of the ICIQ‐OAB, using the ICS terminology. Descriptive statistics were used to evaluate nocturia prevalence. Logistic regression analysis was carried out to determine the association of nocturia with predefined variables.Results: The prevalence of nocturia was 55.9% and it was more common in women than men (53.96% vs. 46.04%; p = .004). At least three episodes of nocturia were observed in 20.37% of the participants who had a severe alteration in their quality of life (p < .01). The bivariate model showed an association between nocturia and obesity (odds ratio [OR], 1.69; 90% confidence interval [CI]: 1.22–2.34), diabetes mellitus (OR, 2.99; 90% CI: 1.86–4.83), high blood pressure (OR, 2.04; 90% CI: 1.52–2.72), cardiovascular disease (OR, 1.75; 90% CI: 1.08 – 2.83), depression (OR, 1.89; 90% CI: 1.23–2.89), obstructive sleep apnea (OR, 1.70; 90% CI: 1.17 ‐ 2.46), and childhood enuresis (OR, 1.45; 90% CI: 1.04–2.02). The multivariate model showed an association with obesity (OR, 2.0; 95% CI: 1.14 ‐ 3.51) in women, as well as age ≥ 65 years (OR, 3.18; 95% CI: 1.26 – 8.02) and erectile dysfunction (OR, 3.44; 95% CI: 1.21 – 9.72) in men. Childhood enuresis was significantly associated with nocturia in both genders (OR, 1.61; 95% CI: 1.09 ‐ 2.40 in women and OR, 1.66; 95% CI: 1.09–2.52 in men).Conclusion: There is a significant prevalence of nocturia in our population and a clear association with impaired quality of life. We consider important to inquire about history of childhood enuresis to define the risk of presenting nocturia in adulthood. Nocturia was associated with multiple comorbidities. Obesity and erectile dysfunction play an important role as modifiable risk factor.
- Open Access
- 4 February 2021
- Published by Instituto Mexicano del Seguro Social in Revista Urología Colombiana / Colombian Urology Journal
- Vol. 30 (02) , 123-134
Infección de vías urinarias no complicada en mujeres
Resumen: La infección de vías urinarias (IVU) es una patología común, que afecta a gran parte de la población y que generalmente se resuelve con manejo antibiótico. Se compone de una amplia variedad de entidades clínicas que pueden variar desde una cistitis no complicada hasta un shock séptico de origen urinario. Los patógenos etiológicos de la IVU no complicada están ampliamente establecidos y se han mantenido de forma consistente a lo largo del tiempo, siendo la Escherichia coli el microorganismo más predominante. En la actualidad, la resistencia bacteriana a los antibióticos es de gran preocupación y por esa razón, se busca optimizar la terapia antimicrobiana con el fin de disminuir la estancia hospitalaria, la severidad clínica de la infección y los costos a los sistemas de salud. La presente revisión, tiene como objetivo servir como guía para la correcta definición, clasificación, diagnóstico, tratamiento y prevención de la IVU no complicada.
- 4 February 2021
- Published by Instituto Mexicano del Seguro Social in Revista Urología Colombiana / Colombian Urology Journal
- Vol. 30 (02) , 123-134
Open AccessInfección de vías urinarias no complicada en mujeres
Resumen: La infección de vías urinarias (IVU) es una patología común, que afecta a gran parte de la población y que generalmente se resuelve con manejo antibiótico. Se compone de una amplia variedad de entidades clínicas que pueden variar desde una cistitis no complicada hasta un shock séptico de origen urinario. Los patógenos etiológicos de la IVU no complicada están ampliamente establecidos y se han mantenido de forma consistente a lo largo del tiempo, siendo la Escherichia coli el microorganismo más predominante. En la actualidad, la resistencia bacteriana a los antibióticos es de gran preocupación y por esa razón, se busca optimizar la terapia antimicrobiana con el fin de disminuir la estancia hospitalaria, la severidad clínica de la infección y los costos a los sistemas de salud. La presente revisión, tiene como objetivo servir como guía para la correcta definición, clasificación, diagnóstico, tratamiento y prevención de la IVU no complicada.
- Open Access
- 2 December 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-7
Present value of the Urethral mobility test as a tool to assess Stress urinary incontinence due to Intrinsic sphincteric deficiency
Q-tip test offers a simple approach for identifying urethral hypermobility. Considering surgical treatment, stress urinary incontinence (SUI) must be classified and the contribution of intrinsic sphincter deficiency (ISD) and/or urethral hypermobility must be determine. We believe there's a correlation between abdominal leak point pressure (ALPP) and urethral mobility degree, and the aim of this study is to explore it using Q-tip. We conducted a prospective study, between years 2014 and 2016. Females over 18 years presenting with signs and symptoms of SUI according to the 2002 ICS Standardization of Terminology were included. Assessment was made with the International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), the Q-tip test and invasive urodynamics. Urethral mobility (UM) and ALPP were analyzed. We built two composite variables based on reported risk factors for ISD, defined as composite variable A (equal to a Q-tip test < 30° AND ICIQ-SF ≥ 10 points) and composite variable B (equal to low urethral mobility AND/OR hypoestrogenism AND/OR history of radiotherapy AND/OR previous pelvic surgery). Correlation analyzes were made according to the type of variable. A total of 221 patients were included. Incontinence was rated as moderate and severe by 65.3% and 6.8%, respectively. The analysis showed a 61.75%, 51.61% and 70.6% agreement between ALPP and UM, ALPP and composite variable A and ALPP and composite variable B respectively. Correlation and concordances were low (r = 0.155, r_s = − 0.053 and r_s = − 0.008), (rho_c = 0.036, k = 0.116 and k = 0.016). Neither the degree of UM, nor the composite variables, correlate or agree with urethral function tests in UDS, suggesting that the ALPP cannot be predicted using the Q-tip test or the ICIQ-SF for classifying patients with SUI.
- 2 December 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-7
Open AccessPresent value of the Urethral mobility test as a tool to assess Stress urinary incontinence due to Intrinsic sphincteric deficiency
Q-tip test offers a simple approach for identifying urethral hypermobility. Considering surgical treatment, stress urinary incontinence (SUI) must be classified and the contribution of intrinsic sphincter deficiency (ISD) and/or urethral hypermobility must be determine. We believe there's a correlation between abdominal leak point pressure (ALPP) and urethral mobility degree, and the aim of this study is to explore it using Q-tip. We conducted a prospective study, between years 2014 and 2016. Females over 18 years presenting with signs and symptoms of SUI according to the 2002 ICS Standardization of Terminology were included. Assessment was made with the International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), the Q-tip test and invasive urodynamics. Urethral mobility (UM) and ALPP were analyzed. We built two composite variables based on reported risk factors for ISD, defined as composite variable A (equal to a Q-tip test < 30° AND ICIQ-SF ≥ 10 points) and composite variable B (equal to low urethral mobility AND/OR hypoestrogenism AND/OR history of radiotherapy AND/OR previous pelvic surgery). Correlation analyzes were made according to the type of variable. A total of 221 patients were included. Incontinence was rated as moderate and severe by 65.3% and 6.8%, respectively. The analysis showed a 61.75%, 51.61% and 70.6% agreement between ALPP and UM, ALPP and composite variable A and ALPP and composite variable B respectively. Correlation and concordances were low (r = 0.155, r_s = − 0.053 and r_s = − 0.008), (rho_c = 0.036, k = 0.116 and k = 0.016). Neither the degree of UM, nor the composite variables, correlate or agree with urethral function tests in UDS, suggesting that the ALPP cannot be predicted using the Q-tip test or the ICIQ-SF for classifying patients with SUI.
- 14 August 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (8) , 2153-2160
Obesity as a risk factor for poor outcomes after sling surgery in women with stress urinary incontinence: A systematic review and meta‐analysis
Purpose: Obesity is one of the main risk factors for stress urinary incontinence (SUI) and has also been associated with worse surgical outcomes. However, the literature is heterogeneous and inconclusive. The goal of this study was to perform a systematic review and meta‐analysis to evaluate cure rates and perioperative complications in obese women.Materials and Methods: A literature search of OVID, MEDNAR, Embase, Scopus, Web of Science, PubMed, and CENTRAL databases was conducted. Randomized controlled trials comparing cure rates and failure of treatment in normal and obese patients, who underwent mid‐urethral sling surgery, were identified. A systematic review of subjective and objective cure rates, and complications was performed. Meta‐analyses of dichotomous data under the random‐effects model were applied using Review Manager 5.3. Nonrandomized comparative studies and gray literature were excluded.Results: A total of 219 studies were identified. Four randomized controlled trials were included for evaluation. The risk of bias evaluation was performed according to the Cochrane Handbook for Systematic Reviews of Interventions. One study was excluded due to missing data on the outcomes. Patients were stratified according to their body mass index as obese (>30 kg/m2) and nonobese (2). Complications could not be meta‐analyzed. The meta‐analysis of subjective (risk ratio [RR] = 1.69 [95% confidence interval [CI]: 1.32‐2.16]) and objective (RR = 1.62 [95% CI: 1.26‐2.07]) cure rates disfavored obese women.Conclusions: This meta‐analysis shows that obesity is a risk factor for the nonsuccessful treatment of SUI with tension‐free mid‐urethral sling. Differences in regards to the surgical approach and its association with obesity could not be established with the current evidence.
- 14 August 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (8) , 2153-2160
Obesity as a risk factor for poor outcomes after sling surgery in women with stress urinary incontinence: A systematic review and meta‐analysis
Purpose: Obesity is one of the main risk factors for stress urinary incontinence (SUI) and has also been associated with worse surgical outcomes. However, the literature is heterogeneous and inconclusive. The goal of this study was to perform a systematic review and meta‐analysis to evaluate cure rates and perioperative complications in obese women.Materials and Methods: A literature search of OVID, MEDNAR, Embase, Scopus, Web of Science, PubMed, and CENTRAL databases was conducted. Randomized controlled trials comparing cure rates and failure of treatment in normal and obese patients, who underwent mid‐urethral sling surgery, were identified. A systematic review of subjective and objective cure rates, and complications was performed. Meta‐analyses of dichotomous data under the random‐effects model were applied using Review Manager 5.3. Nonrandomized comparative studies and gray literature were excluded.Results: A total of 219 studies were identified. Four randomized controlled trials were included for evaluation. The risk of bias evaluation was performed according to the Cochrane Handbook for Systematic Reviews of Interventions. One study was excluded due to missing data on the outcomes. Patients were stratified according to their body mass index as obese (>30 kg/m2) and nonobese (2). Complications could not be meta‐analyzed. The meta‐analysis of subjective (risk ratio [RR] = 1.69 [95% confidence interval [CI]: 1.32‐2.16]) and objective (RR = 1.62 [95% CI: 1.26‐2.07]) cure rates disfavored obese women.Conclusions: This meta‐analysis shows that obesity is a risk factor for the nonsuccessful treatment of SUI with tension‐free mid‐urethral sling. Differences in regards to the surgical approach and its association with obesity could not be established with the current evidence.
- 1 November 2019
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (1) , 303-309
Functional outcomes and safety of GreenLight photovaporization of the prostate in the high‐risk patient with lower urinary tract symptoms due to benign prostatic enlargement
Aims: Photovaporization of the prostate (PVP) with GreenLight Laser is a surgical treatment for lower urinary tract symptoms. It is considered safe in elderly patients with comorbidities, however, the evidence is inconclusive. The objective of this study is to evaluate the efficacy and safety outcomes of PVP according to the American Society of Anesthesiologists Physical Status (ASAPS).Methods: A cohort of 675 patients who underwent PVP between 2012 and 2018 was evaluated. Patients were classified according to their ASAPS as low (I and II) and high risk (III and IV). Surgical characteristics and improvement of symptoms and Quality of Life (QoL) were evaluated.Results: The median age of high‐risk group was higher than low‐risk group. The high‐risk group had more history of anticoagulation, antiaggregation, urinary catheterization, urinary retention and urethral stricture. Longer times of hospitalization (23.7 [interquartile range {IQR} = 18.9‐41.35] vs 21.8 hours [IQR = 18.7‐26.6], P = .008) and catheterization (19.55 [IQR = 15.6‐35.57] vs 17.67 hours [IQR = 14.76‐22.5], P = .004) were found in the high‐risk group. Conversion and bleeding control were not different between groups. In the follow‐up, improvement of International Prostate Symptoms Score (IPSS) and QoL was significant in all patients when compared before and after surgery scores (P < .001). There were no difference between groups for QoL, however, IPSS was lower for the low‐risk group (8 [IQR = 4‐14.5] vs 5 [2‐12], P = .001).Conclusion: PVP with GreenLight Laser is a safe and efficient procedure for all patients despite their comorbidities, with comparable middle‐term outcomes which makes it a standard treatment for the entire aging population, improving their QoL.
- 1 November 2019
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (1) , 303-309
Functional outcomes and safety of GreenLight photovaporization of the prostate in the high‐risk patient with lower urinary tract symptoms due to benign prostatic enlargement
Aims: Photovaporization of the prostate (PVP) with GreenLight Laser is a surgical treatment for lower urinary tract symptoms. It is considered safe in elderly patients with comorbidities, however, the evidence is inconclusive. The objective of this study is to evaluate the efficacy and safety outcomes of PVP according to the American Society of Anesthesiologists Physical Status (ASAPS).Methods: A cohort of 675 patients who underwent PVP between 2012 and 2018 was evaluated. Patients were classified according to their ASAPS as low (I and II) and high risk (III and IV). Surgical characteristics and improvement of symptoms and Quality of Life (QoL) were evaluated.Results: The median age of high‐risk group was higher than low‐risk group. The high‐risk group had more history of anticoagulation, antiaggregation, urinary catheterization, urinary retention and urethral stricture. Longer times of hospitalization (23.7 [interquartile range {IQR} = 18.9‐41.35] vs 21.8 hours [IQR = 18.7‐26.6], P = .008) and catheterization (19.55 [IQR = 15.6‐35.57] vs 17.67 hours [IQR = 14.76‐22.5], P = .004) were found in the high‐risk group. Conversion and bleeding control were not different between groups. In the follow‐up, improvement of International Prostate Symptoms Score (IPSS) and QoL was significant in all patients when compared before and after surgery scores (P < .001). There were no difference between groups for QoL, however, IPSS was lower for the low‐risk group (8 [IQR = 4‐14.5] vs 5 [2‐12], P = .001).Conclusion: PVP with GreenLight Laser is a safe and efficient procedure for all patients despite their comorbidities, with comparable middle‐term outcomes which makes it a standard treatment for the entire aging population, improving their QoL.